New Combination of Nutrients Addresses Three Critical Factors
Chris D. Meletis, ND (with permission from cpmedical.net, access pin: 587556)
In past articles in Vitamin Research News (“Anti-Hypertension Protocol Using Shark Cartilage and Cordyceps Sinesis”) we have discussed how too much parathyroid hypertensive factor (PHF) will increase intracellular calcium and how lowering PHF will reduce calcium entry into vascular smooth muscle, reducing blood pressure. This still remains a very important component of blood pressure control, yet, this is only part of the story. Only 30 percent or more of hypertensive patients have increased PHF levels, leaving a large number of individuals whose hypertension originates due to causes other than high PHF. Nitric Oxide deficiency and the activity of angiotensin-converting enzyme (ACE) are two other equally important factors. Additionally, minimizing arterial calcification also can have impressive effects on blood pressure by improving dilation and blood flow through the arteries. Because physicians can never be certain which of these factors are contributing to an individual patient’s hypertension, they will often experiment with various approaches that address each of these issues until they find the solution.
In this article, I will go beyond the issue of PHF to explain three other causes behind hypertension. I will explain the role that nitric oxide can play in maintaining healthy blood pressure levels. Furthermore, I will discuss how the ACE enzyme is often implicated in high blood pressure and why any blood pressure regimen should also seek to improve arterial function. Finally, I will explain how a new combination of nutritional substances can address all three of these factors.